Inventor · Plymouth, MA, US

Gregory Hinkle

96Patents
10h-index
93Co-inventors
81Inventor score

Filing activity: Jul 10, 2001 → Jul 5, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7314974B2 Expression of microbial proteins in plants for production of plants with improved properties Emerging Cross-Sectional Technologies 122 Expired
US6833447B1 Myxococcus xanthus genome sequences and uses thereof Chemistry; Metallurgy 61 Expired
US8168775B2 Compositions and methods for inhibiting expression of transthyretin Chemistry; Metallurgy 34 Active
US8741866B2 Compositions and methods for inhibiting expression of transthyretin Chemistry; Metallurgy 24 Active
US9234196B2 Compositions and methods for inhibiting expression of transthyretin Chemistry; Metallurgy 13 Active
US8273869B2 Lipid formulated dsRNA targeting the PCSK9 gene Chemistry; Metallurgy 13 Active
US10570393B2 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 12 Active
US8598139B2 Lipid formulated dsRNA targeting the PCSK9 gene Chemistry; Metallurgy 12 Active
US10934544B2 Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof Chemistry; Metallurgy 10 Active
US9574192B2 Serapina1 iRNA compositions and methods of use thereof Chemistry; Metallurgy 10 Active
US10238749B2 Angiotensinogen (AGT) iRNA compositions and methods of use thereof Chemistry; Metallurgy 8 Active
US8324368B2 GNAQ targeted dsRNA compositions and methods for inhibiting expression Chemistry; Metallurgy 8 Active
US10231988B2 Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 6 Active
US10030244B2 Serpina1 iRNA compositions and methods of use thereof Chemistry; Metallurgy 6 Active
US10513703B2 Hepatitis B virus (HBV) iRNA compositions and methods of use thereof Chemistry; Metallurgy 5 Active
US8293718B2 Organic compositions to treat HSF1-related diseases Emerging Cross-Sectional Technologies 5 Active
US10709728B2 Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof Chemistry; Metallurgy 5 Active
US8481509B2 Organic compositions to treat HSF1-related diseases Chemistry; Metallurgy 5 Active
US8623838B2 Organic compositions to treat HSF1-related diseases Emerging Cross-Sectional Technologies 5 Active
US8765932B2 Compositions and methods for inhibiting expression of XBP-1 gene Chemistry; Metallurgy 4 Active
US10407679B2 Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 4 Active
US10240152B2 Compositions and methods for inhibiting expression of transthyretin Chemistry; Metallurgy 4 Active
US11034958B2 Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 4 Active
US10767177B2 Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof Chemistry; Metallurgy 3 Active
US11198872B2 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 3 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.